Description
Product Description
The CycLex AKT/PKB kinase Assay/Inhibitor Screening Kit is designed to measure the activities of purified AKTs for the rapid and sensitive evaluation of inhibitors or activators It can be used for 96 assays.
Product Specifications
| Product Specifications | |
| Application | ELISA |
Documents & Links
| Documents & Links for CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit | |
| Datasheet | CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit Datasheet |
| Documents & Links for CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit | |
| Datasheet | CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit Datasheet |
Citations
| Citations for CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit – 3 Found |
| Mure, Hideo; Matsuzaki, Kazuhito; Kitazato, Keiko T; Mizobuchi, Yoshifumi; Kuwayama, Kazuyuki; Kageji, Teruyoshi; Nagahiro, Shinji. Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro-Oncology. 2010;12(3):221-32. PubMed |
| Bresin, Antonella; Ragone, Gianluca; Cristofoletti, Cristina; Arcelli, Diego; Bassi, Cristian; Caprini, Elisabetta; Fiorenza, Maria Teresa; Helmer Citterich, Mauro; Russo, Giandomenico; Narducci, Maria Grazia. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1. Plos One. 13(10):e0204775. PubMed |
| Uko, Nne E; Güner, Osman F; Bowen, J Phillip; Matesic, Diane F. Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine. Anticancer Research. 2019;39(10):5329-5338. PubMed |